Koninklijke KPN N.V. (KPN.AS)
EUR 4.03
(-1.51%)
EUR 4.03
(-1.51%)
| Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|
| Revenue | 5.43 Billion | 5.31 Billion | 5.27 Billion | 5.28 Billion | 5.49 Billion | 5.63 Billion |
| Cost of Revenue | 2.51 Billion | 2.47 Billion | 1.18 Billion | 1.28 Billion | 1.18 Billion | 1.3 Billion |
| Gross Profit | 2.92 Billion | 2.83 Billion | 4.08 Billion | 4 Billion | 4.31 Billion | 4.33 Billion |
| Operating Expenses | 1.59 Billion | 1.63 Billion | 3.06 Billion | 3.08 Billion | 3.48 Billion | 3.54 Billion |
| Selling, General and Administrative Expenses | 8 Million | 304 Million | 285 Million | 298 Million | 443 Million | 439 Million |
| Research and Development Expenses | 196 Million | 204 Million | 205 Million | 217 Million | 205 Million | - |
| Other Expenses | 1.38 Billion | - | 3.06 Billion | 3.08 Billion | 3.48 Billion | 5 Million |
| Cost and Expenses | 4.09 Billion | 4.1 Billion | 4.24 Billion | 4.36 Billion | 4.66 Billion | 4.85 Billion |
| Operating Income | 1.34 Billion | 1.25 Billion | 1.02 Billion | 912 Million | 767 Million | 789 Million |
| Interest Expense | 266 Million | 214 Million | 223 Million | 238 Million | 298 Million | 315 Million |
| Income Tax Expense | 245 Million | 227 Million | 344 Million | 88 Million | 49 Million | 233 Million |
| Earnings before Tax | 1.08 Billion | 992 Million | 1.62 Billion | 649 Million | 663 Million | 513 Million |
| Net Income | 844 Million | 760 Million | 1.28 Billion | 560 Million | 626 Million | 270 Million |
| Earnings Per Share Basic | 0.20 | 0.18 | 0.31 | 0.13 | 0.15 | 0.06 |
| Earnings Per Share Diluted | 0.20 | 0.18 | 0.31 | 0.13 | 0.15 | 0.06 |
| Weighted Average Shares Outstanding | 3.97 Billion | 4.15 Billion | 4.17 Billion | 4.19 Billion | 4.19 Billion | 4.19 Billion |
| Weighted Average Shares Outstanding (Diluted) | 3.97 Billion | 4.08 Billion | 4.18 Billion | 4.2 Billion | 4.2 Billion | 4.2 Billion |
| Gross Margin | 0.54 | 0.53 | 0.78 | 0.76 | 0.79 | 0.77 |
| EBIT Margin | 0.41 | 0.41 | 0.47 | 0.47 | 0.42 | 0.40 |
| Profit Margin | 0.16 | 0.14 | 0.24 | 0.11 | 0.11 | 0.05 |
| EBITDA | 2.21 Billion | 2.18 Billion | 3.29 Billion | 2.4 Billion | 2.48 Billion | 2.4 Billion |
| Earnings Before Tax Margin | 0.25 | 0.24 | 0.19 | 0.17 | 0.14 | 0.14 |
| Breakdown | 2024 Q2 | 2024 Q1 | 2023 FY | 2023 Q4 | 2023 Q3 | 2023 Q2 |
|---|---|---|---|---|---|---|
| Revenue | 2.76 Billion | 1.37 Billion | 5.43 Billion | 1.39 Billion | 1.36 Billion | 1.33 Billion |
| Cost of Revenue | 1.27 Billion | 640 Million | 2.51 Billion | 679 Million | 609 Million | 607 Million |
| Gross Profit | 1.49 Billion | 731 Million | 2.92 Billion | 714 Million | 759 Million | 723 Million |
| Operating Expenses | 185 Million | 452 Million | 1.59 Billion | 386 Million | 402 Million | 384 Million |
| Selling, General and Administrative Expenses | 185 Million | - | - | 226 Million | - | 190 Million |
| Research and Development Expenses | - | - | - | 196 Million | - | - |
| Other Expenses | 22 Million | - | 1 Million | 26 Million | - | 15 Million |
| Cost and Expenses | 1.45 Billion | 1.09 Billion | 4.1 Billion | 1.06 Billion | 1.01 Billion | 991 Million |
| Operating Income | 1.31 Billion | 348 Million | 1.36 Billion | 321 Million | 379 Million | 333 Million |
| Interest Expense | 71 Million | - | 266 Million | - | - | 64 Million |
| Income Tax Expense | -401 Million | 46 Million | 245 Million | 55 Million | 69 Million | 64 Million |
| Earnings before Tax | 517 Million | 220 Million | 1.08 Billion | 260 Million | 293 Million | 280 Million |
| Net Income | 401 Million | 174 Million | 844 Million | 165 Million | 224 Million | 216 Million |
| Earnings Per Share Basic | 0.09 | 0.04 | - | 0.04 | 0.05 | 0.05 |
| Earnings Per Share Diluted | 0.09 | 0.04 | - | 0.04 | 0.05 | 0.05 |
| Weighted Average Shares Outstanding | 4.35 Billion | 4.28 Billion | 4.01 Billion | 4.29 Billion | 4.52 Billion | 4.32 Billion |
| Weighted Average Shares Outstanding (Diluted) | 4.35 Billion | 4.04 Billion | 3.97 Billion | 4.12 Billion | 4.52 Billion | 4.32 Billion |
| Gross Margin | 0.54 | 0.53 | 0.54 | 0.51 | 0.55 | 0.54 |
| EBIT Margin | 0.62 | 0.45 | - | 0.26 | 0.47 | 0.44 |
| Profit Margin | 0.14 | 0.13 | 0.16 | 0.12 | 0.16 | 0.16 |
| EBITDA | 1.71 Billion | 616 Million | - | 364 Million | 639 Million | 588 Million |
| Earnings Before Tax Margin | 0.47 | 0.25 | 0.25 | 0.23 | 0.28 | 0.25 |
NATCOPHARM
BMET
SXTY
LN
NVMI
CPL